Reference health
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
23/23 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 23 checked references that resolve
resolves10.1016/j.yebeh.2014.08.135
Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
resolves10.1056/NEJMoa1611618
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
resolves10.1212/WNL.0000000000005254
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
resolves10.1016/S0140-6736(18)30136-3
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
resolves10.1016/S1474-4422(15)00379-8
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
resolves10.1111/epi.13499
Cannabidiol as a new treatment for drug‐resistant epilepsy in tuberous sclerosis complex
resolves10.1111/epi.13815
Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open‐label clinical study with cannabidiol
resolves10.1080/13554794.2017.1391294
The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy
resolves10.1016/j.yebeh.2012.04.128
Seizure diaries for clinical research and practice: Limitations and future prospects
resolves10.1016/S1474-4422(16)00120-4
Cannabidiol in patients with treatment-resistant epilepsy – Authors' reply
resolves10.1212/WNL.62.1.23
Systematic screening allows reduction of adverse antiepileptic drug effects
resolves10.1016/j.yebeh.2013.08.037
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
resolves10.1016/j.yebeh.2016.11.020
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy
resolves10.1016/j.yebeh.2015.02.043
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
The 2 references without a DOI — listed, not checked
no DOI — not checkedSzaflarski JP, Bebin EM, Comi A, Patel A, Charuta J, Checketts D, et al. Long-term safety and treatment effects of cannabidiol in children and adults with treatment resistant epilepsies: expanded access program results. Epilepsia. in print.
no DOI — not checkedDevelopment of a patient-based symptom check list to quantify adverse events in persons receiving antiepileptic drugs
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.yebeh.2018.07.020"><img src="https://citestamp.com/citestamped/10.1016/j.yebeh.2018.07.020/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.yebeh.2018.07.020)